Future lines of research on phase angle: Strengths and limitations

Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference model...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Reviews in endocrine & metabolic disorders Ročník 24; číslo 3; s. 563 - 583
Hlavní autori: Bellido, Diego, García-García, Cristina, Talluri, Antonio, Lukaski, Henry C., García-Almeida, José Manuel
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.06.2023
Springer
Springer Nature B.V
Predmet:
ISSN:1389-9155, 1573-2606, 1573-2606
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference models. In particular PhA, have demonstrated their prognostic utility in multiple aspects of health and disease. In recent years, as a strong association between prognostic and diagnostic factors has been observed, scientific interest in the utility of PhA has increased. In the different fields of knowledge in biomedical research, there are different ways of assessing the impact of a scientific-technical aspect such as PhA. Single frequency with phase detection bioimpedance analysis (SF-BIA) using a 50 kHz single frequency device and tetrapolar wrist-ankle electrode placement is the most widely used bioimpedance approach for characterization of whole-body composition. However, the incorporation of vector representation of raw bioelectrical parameters and direct mathematical calculations without the need for regression equations for the analysis of body compartments has been one of the most important aspects for the development of research in this area. These results provide new evidence for the validity of phase-sensitive bioelectrical measurements as biomarkers of fluid and nutritional status. To enable the development of clinical research that provides consistent results, it is essential to establish appropriate standardization of PhA measurement techniques. Standardization of test protocols will facilitate the diagnosis and assessment of the risk associated with reduced PhA and the evaluation of changes in response to therapeutic interventions. In this paper, we describe and overview the value of PhA in biomedical research, technical and instrumental aspects of PhA research, analysis of Areas of clinical research (cancer patients, digestive and liver diseases, critical and surgical patients, Respiratory, infectious, and COVID-19, obesity and metabolic diseases, Heart and kidney failure, Malnutrition and sarcopenia), characterisation of the different research outcomes, Morphofunctional assessment in disease-related malnutrition and other metabolic disorders: validation of PhA with reference clinical practice techniques, strengths and limitations. Based on the detailed study of the measurement technique, some of the key issues to be considered in future PhA research. On the other hand, it is important to assess the clinical conditions and the phenotype of the patients, as well as to establish a disease-specific clinical profile. The appropriate selection of the most critical outcomes is another fundamental aspect of research.
AbstractList Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference models. In particular PhA, have demonstrated their prognostic utility in multiple aspects of health and disease. In recent years, as a strong association between prognostic and diagnostic factors has been observed, scientific interest in the utility of PhA has increased. In the different fields of knowledge in biomedical research, there are different ways of assessing the impact of a scientific-technical aspect such as PhA. Single frequency with phase detection bioimpedance analysis (SF-BIA) using a 50 kHz single frequency device and tetrapolar wrist-ankle electrode placement is the most widely used bioimpedance approach for characterization of whole-body composition. However, the incorporation of vector representation of raw bioelectrical parameters and direct mathematical calculations without the need for regression equations for the analysis of body compartments has been one of the most important aspects for the development of research in this area. These results provide new evidence for the validity of phase-sensitive bioelectrical measurements as biomarkers of fluid and nutritional status. To enable the development of clinical research that provides consistent results, it is essential to establish appropriate standardization of PhA measurement techniques. Standardization of test protocols will facilitate the diagnosis and assessment of the risk associated with reduced PhA and the evaluation of changes in response to therapeutic interventions. In this paper, we describe and overview the value of PhA in biomedical research, technical and instrumental aspects of PhA research, analysis of Areas of clinical research (cancer patients, digestive and liver diseases, critical and surgical patients, Respiratory, infectious, and COVID-19, obesity and metabolic diseases, Heart and kidney failure, Malnutrition and sarcopenia), characterisation of the different research outcomes, Morphofunctional assessment in disease-related malnutrition and other metabolic disorders: validation of PhA with reference clinical practice techniques, strengths and limitations. Based on the detailed study of the measurement technique, some of the key issues to be considered in future PhA research. On the other hand, it is important to assess the clinical conditions and the phenotype of the patients, as well as to establish a disease-specific clinical profile. The appropriate selection of the most critical outcomes is another fundamental aspect of research.Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference models. In particular PhA, have demonstrated their prognostic utility in multiple aspects of health and disease. In recent years, as a strong association between prognostic and diagnostic factors has been observed, scientific interest in the utility of PhA has increased. In the different fields of knowledge in biomedical research, there are different ways of assessing the impact of a scientific-technical aspect such as PhA. Single frequency with phase detection bioimpedance analysis (SF-BIA) using a 50 kHz single frequency device and tetrapolar wrist-ankle electrode placement is the most widely used bioimpedance approach for characterization of whole-body composition. However, the incorporation of vector representation of raw bioelectrical parameters and direct mathematical calculations without the need for regression equations for the analysis of body compartments has been one of the most important aspects for the development of research in this area. These results provide new evidence for the validity of phase-sensitive bioelectrical measurements as biomarkers of fluid and nutritional status. To enable the development of clinical research that provides consistent results, it is essential to establish appropriate standardization of PhA measurement techniques. Standardization of test protocols will facilitate the diagnosis and assessment of the risk associated with reduced PhA and the evaluation of changes in response to therapeutic interventions. In this paper, we describe and overview the value of PhA in biomedical research, technical and instrumental aspects of PhA research, analysis of Areas of clinical research (cancer patients, digestive and liver diseases, critical and surgical patients, Respiratory, infectious, and COVID-19, obesity and metabolic diseases, Heart and kidney failure, Malnutrition and sarcopenia), characterisation of the different research outcomes, Morphofunctional assessment in disease-related malnutrition and other metabolic disorders: validation of PhA with reference clinical practice techniques, strengths and limitations. Based on the detailed study of the measurement technique, some of the key issues to be considered in future PhA research. On the other hand, it is important to assess the clinical conditions and the phenotype of the patients, as well as to establish a disease-specific clinical profile. The appropriate selection of the most critical outcomes is another fundamental aspect of research.
Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference models. In particular PhA, have demonstrated their prognostic utility in multiple aspects of health and disease. In recent years, as a strong association between prognostic and diagnostic factors has been observed, scientific interest in the utility of PhA has increased. In the different fields of knowledge in biomedical research, there are different ways of assessing the impact of a scientific-technical aspect such as PhA. Single frequency with phase detection bioimpedance analysis (SF-BIA) using a 50 kHz single frequency device and tetrapolar wrist-ankle electrode placement is the most widely used bioimpedance approach for characterization of whole-body composition. However, the incorporation of vector representation of raw bioelectrical parameters and direct mathematical calculations without the need for regression equations for the analysis of body compartments has been one of the most important aspects for the development of research in this area. These results provide new evidence for the validity of phase-sensitive bioelectrical measurements as biomarkers of fluid and nutritional status. To enable the development of clinical research that provides consistent results, it is essential to establish appropriate standardization of PhA measurement techniques. Standardization of test protocols will facilitate the diagnosis and assessment of the risk associated with reduced PhA and the evaluation of changes in response to therapeutic interventions. In this paper, we describe and overview the value of PhA in biomedical research, technical and instrumental aspects of PhA research, analysis of Areas of clinical research (cancer patients, digestive and liver diseases, critical and surgical patients, Respiratory, infectious, and COVID-19, obesity and metabolic diseases, Heart and kidney failure, Malnutrition and sarcopenia), characterisation of the different research outcomes, Morphofunctional assessment in disease-related malnutrition and other metabolic disorders: validation of PhA with reference clinical practice techniques, strengths and limitations. Based on the detailed study of the measurement technique, some of the key issues to be considered in future PhA research. On the other hand, it is important to assess the clinical conditions and the phenotype of the patients, as well as to establish a disease-specific clinical profile. The appropriate selection of the most critical outcomes is another fundamental aspect of research.
Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw parameters Resistance (R), Reactance (Xc) and Phase Angle (PhA), we eliminate the bias of using predictive equations based on reference models. In particular PhA, have demonstrated their prognostic utility in multiple aspects of health and disease. In recent years, as a strong association between prognostic and diagnostic factors has been observed, scientific interest in the utility of PhA has increased. In the different fields of knowledge in biomedical research, there are different ways of assessing the impact of a scientific-technical aspect such as PhA. Single frequency with phase detection bioimpedance analysis (SF-BIA) using a 50 kHz single frequency device and tetrapolar wrist-ankle electrode placement is the most widely used bioimpedance approach for characterization of whole-body composition. However, the incorporation of vector representation of raw bioelectrical parameters and direct mathematical calculations without the need for regression equations for the analysis of body compartments has been one of the most important aspects for the development of research in this area. These results provide new evidence for the validity of phase-sensitive bioelectrical measurements as biomarkers of fluid and nutritional status. To enable the development of clinical research that provides consistent results, it is essential to establish appropriate standardization of PhA measurement techniques. Standardization of test protocols will facilitate the diagnosis and assessment of the risk associated with reduced PhA and the evaluation of changes in response to therapeutic interventions. In this paper, we describe and overview the value of PhA in biomedical research, technical and instrumental aspects of PhA research, analysis of Areas of clinical research (cancer patients, digestive and liver diseases, critical and surgical patients, Respiratory, infectious, and COVID-19, obesity and metabolic diseases, Heart and kidney failure, Malnutrition and sarcopenia), characterisation of the different research outcomes, Morphofunctional assessment in disease-related malnutrition and other metabolic disorders: validation of PhA with reference clinical practice techniques, strengths and limitations. Based on the detailed study of the measurement technique, some of the key issues to be considered in future PhA research. On the other hand, it is important to assess the clinical conditions and the phenotype of the patients, as well as to establish a disease-specific clinical profile. The appropriate selection of the most critical outcomes is another fundamental aspect of research.
Audience Academic
Author Talluri, Antonio
García-Almeida, José Manuel
Lukaski, Henry C.
García-García, Cristina
Bellido, Diego
Author_xml – sequence: 1
  givenname: Diego
  orcidid: 0000-0003-0631-2710
  surname: Bellido
  fullname: Bellido, Diego
  organization: Department of Endocrinology and Nutrition, Complejo Hospitalario de Ferrol
– sequence: 2
  givenname: Cristina
  orcidid: 0000-0002-1311-9970
  surname: García-García
  fullname: García-García, Cristina
  organization: PhD Program in Biomedicine, Translational Research and New Health Technologies, Faculty of Medicine, Málaga University
– sequence: 3
  givenname: Antonio
  orcidid: 0000-0001-9399-5526
  surname: Talluri
  fullname: Talluri, Antonio
  organization: PixelCanDo
– sequence: 4
  givenname: Henry C.
  orcidid: 0000-0002-5418-5851
  surname: Lukaski
  fullname: Lukaski, Henry C.
  organization: Department of Kinesiology and Public Health Education, University of North Dakota
– sequence: 5
  givenname: José Manuel
  orcidid: 0000-0001-8570-184X
  surname: García-Almeida
  fullname: García-Almeida, José Manuel
  email: jgarciaalmeida@gmail.com
  organization: Department of Endocrinology and Nutrition, Virgen de La Victoria Hospital, Malaga University, Centro de Investigación Biomédica en Red de La Fisiopatología de La Obesidad Y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Málaga University, Department of Endocrinology and Nutrition, Quironsalud Málaga Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37043140$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URD_gD3BAkbhwSZmJYzvhVioKSJU4AGfLsSe7rhJ7sZMD_x4vu3xVqLJkj0bPOzOe95ydhBiIsecIlwigXmdEFG0NDa-h74DX6hE7Q6F43UiQJyXmXV_3KMQpO8_5DqBB2Ysn7JQraDm2cMbe3qzLmqiafKBcxbFKlMkku61iqHZbk6kyYTPRm-rzkihslm0uCVf42S9m8THkp-zxaKZMz47vBft68-7L9Yf69tP7j9dXt7UVolnqZnSIrUUSwyhAWGHB2k44hY0cqEdjB6dIqt5AZwY5lC-OyJ0TA5K1veMX7NWh7i7FbyvlRc8-W5omEyiuWTcdALblgoK-vIfexTWFMt2ekrJve_UXtTETaR_GuCRj90X1lWoV5xI7LNTlf6hyHM3eFkdGX_L_CF4cm6_DTE7vkp9N-q5_Lb0AzQGwKeacaPyNIOi9s_rgrC7O6p_OalVE3T2RPRpQxvHTw1J-kObSJ2wo_dnGA6ofcOq0mg
CitedBy_id crossref_primary_10_3390_nu16152537
crossref_primary_10_1016_j_clnesp_2024_03_028
crossref_primary_10_3390_nu17152506
crossref_primary_10_1002_ncp_11192
crossref_primary_10_1002_ncp_70042
crossref_primary_10_1088_1742_6596_3014_1_012013
crossref_primary_10_1007_s11259_024_10555_1
crossref_primary_10_1016_j_numecd_2024_06_016
crossref_primary_10_1097_MD_0000000000041122
crossref_primary_10_1186_s12967_025_06963_9
crossref_primary_10_3390_jpm14030258
crossref_primary_10_1016_j_nut_2024_112681
crossref_primary_10_3390_nu15234991
crossref_primary_10_2196_63457
crossref_primary_10_7759_cureus_84455
crossref_primary_10_3390_nu16142221
crossref_primary_10_1016_j_clnesp_2024_11_017
crossref_primary_10_1007_s10067_025_07349_4
crossref_primary_10_1016_j_nut_2024_112601
crossref_primary_10_1038_s41598_025_86825_y
crossref_primary_10_3892_br_2024_1811
crossref_primary_10_61409_V04240287
crossref_primary_10_2490_jjrmc_24036
crossref_primary_10_1016_j_nsa_2023_103927
crossref_primary_10_1007_s40200_025_01590_z
crossref_primary_10_1038_s41598_024_74412_6
crossref_primary_10_1016_j_nutos_2025_05_012
crossref_primary_10_1007_s00421_025_05853_8
crossref_primary_10_1016_j_clnu_2023_12_001
crossref_primary_10_3390_nu16183136
crossref_primary_10_1016_j_nexres_2025_100292
crossref_primary_10_1080_15502783_2025_2536693
crossref_primary_10_3390_nu16010101
crossref_primary_10_1038_s41430_024_01435_7
crossref_primary_10_3390_life14111511
crossref_primary_10_4240_wjgs_v17_i3_100321
crossref_primary_10_3390_nu17091601
crossref_primary_10_2478_joeb_2025_0012
crossref_primary_10_3390_nu16010106
crossref_primary_10_1136_bmjopen_2024_086240
crossref_primary_10_3390_jcm13102784
crossref_primary_10_1111_eci_14218
crossref_primary_10_3390_nu16244348
crossref_primary_10_1002_ncp_11339
crossref_primary_10_1186_s12967_024_05918_w
crossref_primary_10_3390_bios14120622
crossref_primary_10_3389_fnut_2025_1623983
crossref_primary_10_1016_j_endinu_2025_501644
crossref_primary_10_1186_s13102_024_00899_1
crossref_primary_10_1016_j_nut_2024_112637
crossref_primary_10_3390_nu17050919
crossref_primary_10_1186_s12967_025_06159_1
crossref_primary_10_1038_s41598_024_84968_y
crossref_primary_10_1007_s41999_023_00853_3
crossref_primary_10_1007_s00520_024_08954_w
crossref_primary_10_3389_fnut_2024_1474616
crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_107810
crossref_primary_10_1007_s00520_025_09443_4
crossref_primary_10_1186_s12885_024_12378_4
crossref_primary_10_1016_j_nutos_2024_10_012
crossref_primary_10_3390_nu16142245
crossref_primary_10_3389_fnut_2024_1479501
crossref_primary_10_1007_s11154_025_09964_7
crossref_primary_10_1017_jns_2025_23
crossref_primary_10_1038_s41430_024_01410_2
crossref_primary_10_1002_hsr2_70335
crossref_primary_10_1016_j_bioelechem_2024_108799
crossref_primary_10_1016_j_heliyon_2023_e17593
crossref_primary_10_3390_cancers17050886
crossref_primary_10_1088_1361_6579_adfffb
crossref_primary_10_1016_j_nut_2024_112524
crossref_primary_10_3390_jcm14030678
crossref_primary_10_2196_53975
crossref_primary_10_1016_j_clnu_2024_10_001
crossref_primary_10_1016_j_arr_2024_102326
crossref_primary_10_1016_j_archger_2025_105754
crossref_primary_10_1186_s40001_024_02185_9
crossref_primary_10_3390_nu17132129
crossref_primary_10_1007_s11739_025_03857_y
crossref_primary_10_20960_nh_05887
crossref_primary_10_1016_j_nutos_2024_10_006
crossref_primary_10_1136_bmjsem_2025_002667
crossref_primary_10_1016_j_clnesp_2025_07_022
crossref_primary_10_1089_met_2024_0128
crossref_primary_10_1186_s40001_024_01964_8
crossref_primary_10_1109_TNSRE_2025_3581348
crossref_primary_10_63096_medtigo3084224
crossref_primary_10_3390_nu15183923
crossref_primary_10_1016_j_nut_2024_112412
crossref_primary_10_20960_nh_05517
crossref_primary_10_2478_raon_2023_0025
crossref_primary_10_1016_j_clnu_2025_06_007
crossref_primary_10_3390_nu15163599
crossref_primary_10_1038_s41413_025_00455_8
crossref_primary_10_3390_nu17010091
crossref_primary_10_1159_000540683
crossref_primary_10_1590_1984_0462_2025_43_2024277
crossref_primary_10_1007_s11357_024_01448_x
crossref_primary_10_1016_j_clnu_2024_11_008
crossref_primary_10_1016_j_clnu_2025_02_025
crossref_primary_10_1038_s41598_024_78957_4
crossref_primary_10_1002_jcsm_13514
crossref_primary_10_1186_s12944_025_02534_5
crossref_primary_10_1016_j_nut_2025_112960
crossref_primary_10_3390_nu17101620
crossref_primary_10_20960_nh_05901
crossref_primary_10_1007_s40618_023_02258_2
crossref_primary_10_3390_healthcare12020167
crossref_primary_10_1590_1806_9282_20240088
crossref_primary_10_3389_fnut_2025_1580037
crossref_primary_10_7717_peerj_18592
crossref_primary_10_1016_j_jamda_2025_105607
crossref_primary_10_3390_nu16081116
crossref_primary_10_1016_j_clnesp_2025_09_004
Cites_doi 10.1159/000504079
10.1016/j.clnu.2004.06.004
10.1007/s11154-022-09764-3
10.1016/j.clnesp.2018.10.010
10.1016/j.nut.2021.111184
10.1111/j.1523-1755.2004.00881.x
10.5867/medwave.2021.02.8109
10.1111/sdi.12790
10.1038/s41598-018-21226-y
10.1016/j.clnu.2019.07.004
10.1038/ki.1996.535
10.1016/j.clnu.2021.03.008
10.3390/nu11040809
10.1007/s11154-022-09747-4
10.3390/nu14132726
10.1159/000313727
10.1016/j.endinu.2022.03.008
10.3390/nu14081573
10.1002/ajhb.20078
10.1038/s41430-018-0159-1
10.1038/s41430-022-01131-4
10.3945/ajcn.115.116772
10.1016/j.cardfail.2022.08.005
10.1038/ki.1994.305
10.1016/j.nut.2022.111960
10.1007/s11255-017-1698-4
10.1155/2022/7165126
10.1002/ncp.10016
10.1001/jama.281.13.1214
10.1681/ASN.2005070756
10.1111/aas.13924
10.1007/s11154-022-09775-0
10.1016/S0300-8932(10)70155-X
10.3390/nu14234988
10.1007/s11192-009-0146-3
10.1159/000353863
10.23736/S0022-4707.21.12727-6
10.1038/ejcn.2015.126
10.1038/ejcn.2012.149
10.1002/ncp.10901
10.3390/nu15010050
10.1007/s11695-011-0570-3
10.1016/S0899-9007(99)00147-1
10.1177/0148607106030004309
10.1111/j.1523-1755.2005.00083.x
10.3389/fcvm.2021.744243
10.1038/s41430-018-0355-z
10.3390/nu14163377
10.1097/MCO.0000000000000387
10.1002/ncp.10100
10.1586/17434440.5.2.239
10.1016/j.clnu.2020.06.011
10.1007/s11154-022-09776-z
10.3390/nu14091851
10.1016/j.jclinepi.2010.04.026
10.3390/nu11051092
10.1016/j.exger.2014.07.009
10.1016/j.clnu.2012.05.008
10.1007/s11154-022-09757-2
10.3390/ijerph20021608
10.1097/00075197-200309000-00008
10.1111/j.1523-1755.1998.00843.x
10.1093/ajcn/64.3.503S
10.1016/j.clnu.2020.06.020
10.1111/j.1523-1755.2004.00660.x
10.3390/jcm12010056
10.3390/nu15030612
10.1142/S021951942240053X
10.1001/jama.282.11.1061
10.1111/j.1749-6632.1999.tb09451.x
10.1016/j.clnu.2013.08.007
10.1007/s00592-003-0088-9
10.1007/s11154-023-09785-6
10.1016/j.clnu.2021.07.035
10.1007/s11154-023-09786-5
10.1186/s13089-020-00163-w
10.3390/cancers14082002
10.1007/s11154-022-09774-1
10.1053/j.ajkd.2018.03.030
10.3390/nu15030522
10.1016/j.clnu.2021.01.027
10.3390/cancers15030847
10.1016/j.clnu.2020.10.048
10.1111/sdi.13084
10.1016/j.aprim.2013.12.013
10.1054/clnu.2002.0616
10.1016/j.clnu.2022.10.010
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
COPYRIGHT 2023 Springer
Copyright Springer Nature B.V. Jun 2023
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
– notice: COPYRIGHT 2023 Springer
– notice: Copyright Springer Nature B.V. Jun 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s11154-023-09803-7
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Zoology
EISSN 1573-2606
EndPage 583
ExternalDocumentID A747336181
37043140
10_1007_s11154_023_09803_7
Genre Journal Article
Review
GroupedDBID ---
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
1N0
1SB
203
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
4.4
406
408
409
40D
40E
53G
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDZB
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYFIA
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
ITC
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
P2P
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RIG
RNI
ROL
RPX
RRX
RSV
RZC
RZE
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
ZMTXR
ZOVNA
~A9
~KM
AAYXX
ABFSG
ABRTQ
ACSTC
AEZWR
AFFHD
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PJZUB
PPXIY
-5E
-5G
-BR
-EM
3V.
ADINQ
CGR
CUY
CVF
ECM
EIF
GQ6
NPM
Z7U
Z82
Z87
7QP
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c552t-2fd114c1e5bf505c5c0cc85d7126be91acbd7e679a08ab6b100f13dd5b1ecc9d3
IEDL.DBID RSV
ISICitedReferencesCount 120
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000967640300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1389-9155
1573-2606
IngestDate Sun Sep 28 06:42:55 EDT 2025
Wed Nov 05 08:39:56 EST 2025
Sat Nov 29 13:50:50 EST 2025
Sat Nov 29 10:28:11 EST 2025
Wed Feb 19 02:24:17 EST 2025
Tue Nov 18 22:20:49 EST 2025
Sat Nov 29 08:00:53 EST 2025
Wed Apr 09 21:59:31 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Outcome research
Phase sensitive bioelectrical impedance analysis
Bioelectrical impedance vector analysis
Phase angle
Body composition
Morphofunctional assessment
Language English
License 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c552t-2fd114c1e5bf505c5c0cc85d7126be91acbd7e679a08ab6b100f13dd5b1ecc9d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-0631-2710
0000-0002-5418-5851
0000-0002-1311-9970
0000-0001-9399-5526
0000-0001-8570-184X
OpenAccessLink https://link.springer.com/content/pdf/10.1007/s11154-023-09803-7.pdf
PMID 37043140
PQID 2806694970
PQPubID 44711
PageCount 21
ParticipantIDs proquest_miscellaneous_2800148000
proquest_journals_2806694970
gale_infotracmisc_A747336181
gale_infotracacademiconefile_A747336181
pubmed_primary_37043140
crossref_primary_10_1007_s11154_023_09803_7
crossref_citationtrail_10_1007_s11154_023_09803_7
springer_journals_10_1007_s11154_023_09803_7
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Germany
PublicationTitle Reviews in endocrine & metabolic disorders
PublicationTitleAbbrev Rev Endocr Metab Disord
PublicationTitleAlternate Rev Endocr Metab Disord
PublicationYear 2023
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References O Di Vincenzo (9803_CR11) 2021; 40
JM García Almeida (9803_CR6) 2021; 38
RF Kushner (9803_CR54) 1996; 64
A Piccoli (9803_CR60) 1998; 53
I Cornejo-Pareja (9803_CR91) 2022; 14
9803_CR96
FM van der Sande (9803_CR57) 2020; 49
L Matthews (9803_CR12) 2021; 40
S Praget-Bracamontes (9803_CR16) 2023; 20
HC Lukaski (9803_CR66) 2017; 20
S Rinaldi (9803_CR18) 2019; 29
M Dittmar (9803_CR71) 2004; 16
MME Pereira (9803_CR8) 2018; 33
A Piccoli (9803_CR49) 2010; 164
Y Wang (9803_CR52) 2021; 49
9803_CR50
9803_CR94
9803_CR92
UG Kyle (9803_CR45) 2004; 23
O Di Vincenzo (9803_CR15) 2021; 40
A Piccoli (9803_CR58) 2005; 67
N Jiang (9803_CR36) 2022; 15
P Eusebi (9803_CR79) 2013; 36
MC Gonzalez (9803_CR35) 2016; 103
BR Di Iorio (9803_CR59) 2004; 65
M Tabinor (9803_CR28) 2018; 8
9803_CR64
JG Lijmer (9803_CR81) 1999; 282
J Lima (9803_CR20) 2022; 41
9803_CR3
9803_CR2
9803_CR23
HC Lukaski (9803_CR56) 2019; 11
B Fernández-Medina (9803_CR85) 2022; 69
A Bosy-Westphal (9803_CR69) 2006; 30
9803_CR4
A Jiménez (9803_CR26) 2012; 22
I Cornejo-Pareja (9803_CR43) 2022; 14
W Beaubien-Souligny (9803_CR51) 2020; 12
O Di Vincenzo (9803_CR95) 2022; 108
LM Garlini (9803_CR5) 2019; 73
A Piccoli (9803_CR24) 1994; 46
EAS Alves (9803_CR17) 2022; 37
HC Lukaski (9803_CR1) 1999; 873
E Polak-Szczybyło (9803_CR47) 2022; 12
9803_CR29
9803_CR27
C Basile (9803_CR73) 2014; 58
D Morlino (9803_CR9) 2022; 14
JR Matthie (9803_CR31) 2008; 5
D Primo (9803_CR90) 2022; 2022
9803_CR75
N Bansal (9803_CR61) 2018; 72
9803_CR78
A Piccoli (9803_CR65) 2014; 33
R Fernández-Jiménez (9803_CR86) 2022; 14
I Cornejo-Pareja (9803_CR22) 2021; S0261–5614
L Pillon (9803_CR53) 2004; 66
9803_CR70
AM Richards (9803_CR76) 2010; 63
C Picó (9803_CR77) 2019; 11
E Cereda (9803_CR72) 2021; 40
9803_CR39
9803_CR38
M Kirmayr (9803_CR83) 2021; 21
C García-García (9803_CR89) 2023; 15
AD Lorenzo (9803_CR25) 2003; 6
R Mattiello (9803_CR19) 2020; 39
K Norman (9803_CR32) 2012; 31
Q Maggiore (9803_CR62) 1996; 50
9803_CR87
AM Silva (9803_CR30) 2019; 73
9803_CR42
9803_CR41
JJ López-Gómez (9803_CR93) 2022; 14
AD Martins (9803_CR10) 2022; 62
9803_CR40
9803_CR84
9803_CR46
V Bellizzi (9803_CR63) 2006; 17
9803_CR44
9803_CR88
KJ Mayne (9803_CR14) 2022; 28
A Arab (9803_CR7) 2021; 40
F Slinde (9803_CR33) 2003; 22
9803_CR80
JM Madsen (9803_CR13) 2021; 65
EL de Borba (9803_CR21) 2022; 76
P Kotanko (9803_CR67) 2019; 32
HC Lukaski (9803_CR68) 2013; 67
O Grundmann (9803_CR37) 2015; 69
9803_CR48
A Covic (9803_CR55) 2017; 49
G Guyatt (9803_CR82) 2011; 64
KJ Ellis (9803_CR34) 1999; 15
N de Moraes Santana (9803_CR74) 2018; 33
References_xml – volume: 49
  start-page: 178
  year: 2020
  ident: 9803_CR57
  publication-title: Blood Purif
  doi: 10.1159/000504079
– volume: 23
  start-page: 1226
  year: 2004
  ident: 9803_CR45
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2004.06.004
– ident: 9803_CR4
  doi: 10.1007/s11154-022-09764-3
– volume: 29
  start-page: 1
  year: 2019
  ident: 9803_CR18
  publication-title: Clin Nutr ESPEN
  doi: 10.1016/j.clnesp.2018.10.010
– ident: 9803_CR39
  doi: 10.1016/j.nut.2021.111184
– volume: 66
  start-page: 1266
  year: 2004
  ident: 9803_CR53
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00881.x
– volume: 21
  start-page: e8109
  year: 2021
  ident: 9803_CR83
  publication-title: Medwave
  doi: 10.5867/medwave.2021.02.8109
– volume: 32
  start-page: 223
  year: 2019
  ident: 9803_CR67
  publication-title: Semin Dial
  doi: 10.1111/sdi.12790
– volume: 8
  start-page: 4441
  year: 2018
  ident: 9803_CR28
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-21226-y
– volume: 39
  start-page: 1411
  year: 2020
  ident: 9803_CR19
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2019.07.004
– volume: 50
  start-page: 2103
  year: 1996
  ident: 9803_CR62
  publication-title: Kidney Int
  doi: 10.1038/ki.1996.535
– volume: 40
  start-page: 2914
  year: 2021
  ident: 9803_CR12
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2021.03.008
– volume: 11
  start-page: 809
  year: 2019
  ident: 9803_CR56
  publication-title: Nutrients
  doi: 10.3390/nu11040809
– ident: 9803_CR75
  doi: 10.1007/s11154-022-09747-4
– volume: 14
  start-page: 2726
  year: 2022
  ident: 9803_CR43
  publication-title: Nutrients
  doi: 10.3390/nu14132726
– volume: 164
  start-page: 143
  year: 2010
  ident: 9803_CR49
  publication-title: Contrib Nephrol
  doi: 10.1159/000313727
– ident: 9803_CR88
  doi: 10.1016/j.endinu.2022.03.008
– volume: 14
  start-page: 1573
  year: 2022
  ident: 9803_CR93
  publication-title: Nutrients
  doi: 10.3390/nu14081573
– volume: 49
  start-page: 300060521103106
  year: 2021
  ident: 9803_CR52
  publication-title: J Int Med Res
– volume: 16
  start-page: 697
  year: 2004
  ident: 9803_CR71
  publication-title: Am J Hum Biol
  doi: 10.1002/ajhb.20078
– volume: 73
  start-page: 495
  year: 2019
  ident: 9803_CR5
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-018-0159-1
– volume: 76
  start-page: 1366
  year: 2022
  ident: 9803_CR21
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-022-01131-4
– volume: 103
  start-page: 712
  year: 2016
  ident: 9803_CR35
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.115.116772
– volume: 28
  start-page: 1628
  year: 2022
  ident: 9803_CR14
  publication-title: J Card Fail
  doi: 10.1016/j.cardfail.2022.08.005
– volume: 46
  start-page: 534
  year: 1994
  ident: 9803_CR24
  publication-title: Kidney Int
  doi: 10.1038/ki.1994.305
– volume: 108
  start-page: 111960
  year: 2022
  ident: 9803_CR95
  publication-title: Nutrition
  doi: 10.1016/j.nut.2022.111960
– volume: 49
  start-page: 2231
  year: 2017
  ident: 9803_CR55
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-017-1698-4
– volume: 2022
  start-page: 7165126
  year: 2022
  ident: 9803_CR90
  publication-title: Dis Markers
  doi: 10.1155/2022/7165126
– volume: 33
  start-page: 232
  year: 2018
  ident: 9803_CR74
  publication-title: Nutr Clin Pract.
  doi: 10.1002/ncp.10016
– ident: 9803_CR80
  doi: 10.1001/jama.281.13.1214
– ident: 9803_CR96
– volume: 17
  start-page: 1481
  year: 2006
  ident: 9803_CR63
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005070756
– volume: 65
  start-page: 1155
  year: 2021
  ident: 9803_CR13
  publication-title: Acta Anaesthesiol Scand
  doi: 10.1111/aas.13924
– ident: 9803_CR46
  doi: 10.1007/s11154-022-09775-0
– volume: 63
  start-page: 635
  year: 2010
  ident: 9803_CR76
  publication-title: Rev Esp Cardiol
  doi: 10.1016/S0300-8932(10)70155-X
– volume: 14
  start-page: 4988
  year: 2022
  ident: 9803_CR91
  publication-title: Nutrients
  doi: 10.3390/nu14234988
– ident: 9803_CR23
  doi: 10.1007/s11192-009-0146-3
– volume: 38
  start-page: 592
  year: 2021
  ident: 9803_CR6
  publication-title: Nutr Hosp
– volume: 36
  start-page: 267
  year: 2013
  ident: 9803_CR79
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000353863
– volume: 62
  start-page: 1255
  year: 2022
  ident: 9803_CR10
  publication-title: J Sports Med Phys Fitness
  doi: 10.23736/S0022-4707.21.12727-6
– volume: 69
  start-page: 1290
  year: 2015
  ident: 9803_CR37
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2015.126
– volume: 67
  start-page: S2
  issue: Suppl 1
  year: 2013
  ident: 9803_CR68
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2012.149
– volume: 37
  start-page: 1105
  year: 2022
  ident: 9803_CR17
  publication-title: Nutr Clin Pract
  doi: 10.1002/ncp.10901
– volume: 15
  start-page: 50
  year: 2022
  ident: 9803_CR36
  publication-title: Nutrients
  doi: 10.3390/nu15010050
– volume: 22
  start-page: 587
  year: 2012
  ident: 9803_CR26
  publication-title: Obes Surg
  doi: 10.1007/s11695-011-0570-3
– volume: 15
  start-page: 874
  year: 1999
  ident: 9803_CR34
  publication-title: Nutrition
  doi: 10.1016/S0899-9007(99)00147-1
– volume: 30
  start-page: 309
  year: 2006
  ident: 9803_CR69
  publication-title: JPEN J Parenter Enteral Nutr
  doi: 10.1177/0148607106030004309
– volume: 67
  start-page: 301
  year: 2005
  ident: 9803_CR58
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2005.00083.x
– ident: 9803_CR48
  doi: 10.3389/fcvm.2021.744243
– volume: 73
  start-page: 1077
  year: 2019
  ident: 9803_CR30
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-018-0355-z
– ident: 9803_CR92
  doi: 10.3390/nu14163377
– ident: 9803_CR64
  doi: 10.1097/MCO.0000000000000387
– volume: 33
  start-page: 813
  year: 2018
  ident: 9803_CR8
  publication-title: Nutr Clin Pract
  doi: 10.1002/ncp.10100
– volume: 5
  start-page: 239
  year: 2008
  ident: 9803_CR31
  publication-title: Expert Rev Med Devices
  doi: 10.1586/17434440.5.2.239
– volume: 40
  start-page: 615
  year: 2021
  ident: 9803_CR72
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2020.06.011
– ident: 9803_CR38
  doi: 10.1007/s11154-022-09776-z
– ident: 9803_CR3
– volume: 14
  start-page: 1851
  year: 2022
  ident: 9803_CR86
  publication-title: Nutrients
  doi: 10.3390/nu14091851
– volume: 64
  start-page: 383
  year: 2011
  ident: 9803_CR82
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.04.026
– volume: 11
  start-page: 1092
  year: 2019
  ident: 9803_CR77
  publication-title: Nutrients
  doi: 10.3390/nu11051092
– volume: 58
  start-page: 43
  year: 2014
  ident: 9803_CR73
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2014.07.009
– volume: 31
  start-page: 854
  year: 2012
  ident: 9803_CR32
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2012.05.008
– volume: 69
  start-page: 466
  year: 2022
  ident: 9803_CR85
  publication-title: Endocrinol Diabetes Nutr (Engl Ed)
– ident: 9803_CR50
  doi: 10.1007/s11154-022-09757-2
– volume: 20
  start-page: 1608
  year: 2023
  ident: 9803_CR16
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph20021608
– volume: 6
  start-page: 551
  year: 2003
  ident: 9803_CR25
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/00075197-200309000-00008
– volume: 53
  start-page: 1036
  year: 1998
  ident: 9803_CR60
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.1998.00843.x
– volume: 64
  start-page: 503S
  year: 1996
  ident: 9803_CR54
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/64.3.503S
– ident: 9803_CR40
  doi: 10.1016/j.clnu.2020.06.020
– volume: 65
  start-page: 2435
  year: 2004
  ident: 9803_CR59
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00660.x
– volume: 12
  start-page: 56
  year: 2022
  ident: 9803_CR47
  publication-title: J Clin Med
  doi: 10.3390/jcm12010056
– ident: 9803_CR94
  doi: 10.3390/nu15030612
– ident: 9803_CR27
  doi: 10.1142/S021951942240053X
– volume: 282
  start-page: 1061
  year: 1999
  ident: 9803_CR81
  publication-title: JAMA
  doi: 10.1001/jama.282.11.1061
– volume: 873
  start-page: 72
  year: 1999
  ident: 9803_CR1
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1999.tb09451.x
– ident: 9803_CR78
– volume: 33
  start-page: 673
  year: 2014
  ident: 9803_CR65
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2013.08.007
– ident: 9803_CR70
  doi: 10.1007/s00592-003-0088-9
– ident: 9803_CR41
  doi: 10.1007/s11154-023-09785-6
– volume: 40
  start-page: 5238
  year: 2021
  ident: 9803_CR15
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2021.07.035
– ident: 9803_CR42
  doi: 10.1007/s11154-023-09786-5
– volume: 12
  start-page: 16
  year: 2020
  ident: 9803_CR51
  publication-title: Ultrasound J
  doi: 10.1186/s13089-020-00163-w
– ident: 9803_CR2
– volume: 14
  start-page: 2002
  year: 2022
  ident: 9803_CR9
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14082002
– volume: S0261–5614
  start-page: 00091
  issue: 21
  year: 2021
  ident: 9803_CR22
  publication-title: Clin Nutr
– ident: 9803_CR44
  doi: 10.1007/s11154-022-09774-1
– volume: 72
  start-page: 662
  year: 2018
  ident: 9803_CR61
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2018.03.030
– volume: 15
  start-page: 522
  year: 2023
  ident: 9803_CR89
  publication-title: Nutrients
  doi: 10.3390/nu15030522
– volume: 40
  start-page: 3182
  year: 2021
  ident: 9803_CR7
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2021.01.027
– ident: 9803_CR87
  doi: 10.3390/cancers15030847
– volume: 40
  start-page: 3052
  year: 2021
  ident: 9803_CR11
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2020.10.048
– ident: 9803_CR29
  doi: 10.1111/sdi.13084
– ident: 9803_CR84
  doi: 10.1016/j.aprim.2013.12.013
– volume: 22
  start-page: 153
  year: 2003
  ident: 9803_CR33
  publication-title: Clin Nutr
  doi: 10.1054/clnu.2002.0616
– volume: 20
  start-page: 330
  year: 2017
  ident: 9803_CR66
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0000000000000387
– volume: 41
  start-page: 2801
  year: 2022
  ident: 9803_CR20
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2022.10.010
SSID ssj0021695
Score 2.6410334
SecondaryResourceType review_article
Snippet Bioelectrical impedance analysis (BIA) is the most widely used technique in body composition analysis. When we focus the use of phase sensitive BIA on its raw...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 563
SubjectTerms Analysis
Ankle
Biomarkers
Biomedical research
Body composition
Body Composition - physiology
Clinical trials
COVID-19
Diabetes
Diagnosis
Disease
Electric Impedance
Endocrinology
Functional morphology
Health aspects
Heart diseases
Humans
Internal Medicine
Liver cancer
Liver diseases
Malnutrition
Mathematical models
Measurement techniques
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Metabolic disorders
Metabolism
Nutritional Status
Obesity
Phenotypes
Renal failure
Sarcopenia
Standardization
Therapeutic applications
Wrist
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BeagXHqXQQEFBQuIAVpPYsRMuqCBWXKg4gLTiYvmVbqWSLM2W38-M17vLVqIXrvFDjmfG87K_AXjVNVxIYySrpbJMWFEx47xinS2tM23lhWtisQl1ctJMp-3XFHAb07XK1ZkYD2o_OIqRH1EGULaiVcX7-S9GVaMou5pKaNyEW1Q2m_hcTTcOVylj1RXKxTHCQU-PZpZP5wiHhqHGYkXbFJypLcV09Xj-Sz9dSZhGPTS5_79_8ADuJQs0P16yzEO4Efo9uPsl5dj34M6PIYbaH8GHSQQcyckSHfOhyxMy0Cwf-nw-Q_2Xm_70PLzLKbfdny5mI37w2P9nQv4e9-H75NO3j59ZqrnAXF1XC1Z1Hj0kV4badmgcudoVzjW1V2UlbWhL46xXQarWFI2x0uJmdiX3vrYlMkPr-WPY6Yc-HEDeBPS9fSXwaO8E56Hl3EZ8OokzKxEyKFcbrl1aFtXFONcbKGUikkYi6UgkrTJ4sx4zX8JxXNv7NdFRk6zizM6kJwe4PkK90sfoS3Eu0cjJ4HCrJ8qY225ekVQnGR_1hp4ZvFw300i6t9aH4TL2oZAt6p0Mniw5aL1urgjYSGDL2xVLbSb_9089vX4tz2C3ilxNgaJD2FlcXIbncNv9XpyNFy-ifPwBcP8RwA
  priority: 102
  providerName: ProQuest
Title Future lines of research on phase angle: Strengths and limitations
URI https://link.springer.com/article/10.1007/s11154-023-09803-7
https://www.ncbi.nlm.nih.gov/pubmed/37043140
https://www.proquest.com/docview/2806694970
https://www.proquest.com/docview/2800148000
Volume 24
WOSCitedRecordID wos000967640300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1573-2606
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021695
  issn: 1389-9155
  databaseCode: RSV
  dateStart: 20000201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RFhAXHuUVKCsjIXEAS0ns2DG3FnXFhVXFSysuVvxIF6kkVbPl9zP2OrtsBUhwiaJ4Yo3Hj5nxeD4DvGhrxkXTCFoJaSg3vKSNdZK2pjC2UaXjto6XTcjZrJ7P1UlKChvG0-5jSDKu1Jtkt4AcQ1HH0FzVOaNyB_aq8Bp89I9f1m5WIeJdKyECRwP6eUqV-X0dW-ro6qL8i1a6EiaN2md65__4vgu3k7VJDlfD4x5c890-3Hyf4un7cONrH7fV78PRNIKLkGB1DqRvSUIBWpC-I-cL1HWk6U7P_BsS4tjd6XIx4AeH9N8TyvfwAD5Pjz-9fUfT_QrUVlW5pGXr0Buyha9Mi4aQrWxubV05WZTCeFU01jjphVRNXjdGGGxOWzDnKlNgxyvHHsJu13f-MZDao5_tSo7LeMsZ84oxE7HoBNYsuc-gGMWsbWIr3IFxpjewyUFMGsWko5i0zODV-p_zFfTGX6lfht7TYV5izbZJ6QXIX0C40ofoNzEm0KDJ4GCLEueT3S4e-1-n-TzoEH8WiiuZZ_B8XRz-DGfUOt9fRpqwPYs6JoNHq3Gz5pvJAGLEseT1OEg2lf-5UU_-jfwp3CrjOAubRAewu7y49M_guv2x_DZcTGBHzmV81hPYOzqenXyYxJnzE6CECxw
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8rzwKAUCBYIE4kAtkjixEySEymPVqu2KQ5FWXEz8SBepJEuzBfGn-I3MeJNdthK99cA1diw7-Tyfx2N_A_C0ynkqylKwTEjNUp0mrDRWskrH2pRFYlOT-2QTcjjMR6Pi4wr87u_C0LHK3iZ6Q20bQ3vkLykCKIq0kNGbyXdGWaMoutqn0JjBYtf9-okuW_t65z3-32dJMvhw8G6bdVkFmMmyZMqSyqIPYGKX6Qrp32QmMibPrIwToV0Rl0Zb6YQsyigvtdBxFFUxtzbTMQ63sBzbvQAX0Y5LcvbkaOHgxcJneaHYHyPd9e6SzuyqHuneMGRIFhV5xJlcIsLTdPAXH54K0HreG9z4377YTbjerbDDrdmUuAUrrl6DK_vdGYI1uPy58aGE2_B24AVVQlppt2FThZ3y0Ths6nAyRn4Py_rwyL0KKXZfH07HLT6wWP9bp2zersOncxnLHVitm9rdgzB3USpskiJ1VSnnruBce_09gS3L1AUQ9z9Yma5blPfjSC2kogkUCkGhPCiUDODF_J3JTG7kzNrPCTeKbBG2bMruSgX2j1S91Bb6ipwLXMQFsLFUE22IWS7uIaQ6G9aqBX4CeDIvpjfpXF7tmhNfh7akkVcDuDtD7LzfXJJwU4olmz2EF43_e1D3z-7LY7i6fbC_p_Z2hrsP4FriZxRtim3A6vT4xD2ES-bH9Gt7_MjPzRC-nDe0_wCiuHFr
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLVRceJRXoECQQBzAahI7doKEUEu7oiqsVohKFZcQP9JFKsnSbEH8NX4dY8fZZSvRWw9c44fs-PPM2OP5BuBplVHGy5KTlAtJmGQJKZUWpJKxVGWeaKYyl2xCjEbZ4WE-XoHffSyMfVbZy0QnqHWj7B35pvUA8pzlItqs_LOI8c7wzfQ7sRmkrKe1T6fRQWTf_PqJx7f29d4OrvWzJBnufnr7jvgMA0SlaTIjSaXxPKBik8oKTQGVqkipLNUiTrg0eVwqqYXhIi-jrJRcxlFUxVTrVMY49VxT7PcSrAo0MtgAVrd3R-OP8-NezF3OF-sJJJaF3YfsdIF7lgWHoL4kUZ5FlIgltXhWOfylHc-4a50WHF7_n__fDbjmbe9wq9ssN2HF1Ouw9sG_LliHK58b52S4BdtDR7USWhu8DZsq9JxIk7Cpw-kENX9Y1kfH5lVovfr10WzS4geN9b95zvP2NhxcyFzuwKBuanMPwsxEjOuEoVKrGKUmp1Q6Zj6OPQtmAoj7xS6UH5bNCHJcLEikLUAKBEjhAFKIAF7M20w7IpJzaz-3GCqslMKeVemDLXB8lu-r2MJTJKUczbsANpZqonRRy8U9nAov3dpigaUAnsyLbUv7Yq82zamrYy-rUeMGcLdD73zcVFhKJ4YlL3s4Lzr_96Tunz-Wx7CGiC7e7432H8DVxG0ue1u2AYPZyal5CJfVj9nX9uSR36ghfLlobP8Bms17iw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Future+lines+of+research+on+phase+angle%3A+Strengths+and+limitations&rft.jtitle=Reviews+in+endocrine+%26+metabolic+disorders&rft.au=Bellido%2C+Diego&rft.au=Garc%C3%ADa-Garc%C3%ADa%2C+Cristina&rft.au=Talluri%2C+Antonio&rft.au=Lukaski%2C+Henry+C&rft.date=2023-06-01&rft.pub=Springer&rft.issn=1389-9155&rft.volume=24&rft.issue=3&rft.spage=563&rft_id=info:doi/10.1007%2Fs11154-023-09803-7&rft.externalDocID=A747336181
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1389-9155&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1389-9155&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1389-9155&client=summon